In the future, our task is to further confirm the role of several specific inhibitors of LAT1 in the treatment of various tumors and study its therapeutic effects on inflammation, immune-abnormal diseases, and insulin resistance to provide a new concept for the treatment of LAT1-related diseases. This evidence concerns the gene SLC7A5 and Insulin resistance.